Watch Ticker

Citius Pharmaceuticals Inc. Common

Go to Citius Pharmaceuticals Inc. Common Website

$1.37

0.08 (6.20%)

Live

Previous Close

$1.29

Day Range

$1.3 - $1.39

Previous Day Range

$1.26 - $1.333

Market Cap

$14.4 million USD

Day Vol.

174283

Previous Day Vol.

316579

Currency

USD

Primary Exchange

Nasdaq

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Citius Oncology Announces Pricing of $9.0 Million Public Offering

Citius Oncology priced a public offering of 6,818,182 shares and warrants at $1.32 per share, expecting to raise approximately $9.0 million to support LYMPHIR commercialization and general corporate purposes.

Related tickers: CTOR, CTXR.

Read Full Article

Prnewswire - Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules

Citius Pharmaceuticals announced the closing of a registered direct offering of up to $15.8 million, with $6 million in upfront proceeds and up to an additional $9.8 million from the exercise of short-term warrants. The company plans to use the funds to support the commercial launch of its approved product LYMPHIR and for general corporate purposes.

Related tickers: CTXR.

Read Full Article

Trending Tickers

Please sign in to view